The Minnesota Vikings have a future QB controversy on their hands and rumors about a JJ McCarthy trade are officially here.

The renowned NFL insider revealed that "a few" suitors are interested in the possibility of trading for the team's head coach ...

JPMorgan keeps an Overweight rating and $80 price target on Viking Therapeutics (VKTX) after the company announced that it has initiated the ...

Viking Global Investors makes bold bets in finance sector with top holdings in US Bancorp, Visa, and Progressive Corp.

The Minnesota Vikings dodged the mess that former starting quarterback Kirk Cousins is now navigating with the Atlanta Falco.

As the prospect of Darnold staying with the Vikings beyond this season looks more realistic, trade theories have surfaced since ESPN’s Adam Schefter guaranteed that the Vikings will listen to ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $42.68 which represents a slight increase of $0.33 or 0.78% from the prior close of $42.35. The stock opened at $41.94 and ...

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.04%.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance ...

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $40.25, indicating a +1.19% shift from the previous trading day.